Literature DB >> 7860062

The PKU mutation S349P causes complete loss of catalytic activity in the recombinant phenylalanine hydroxylase enzyme.

P M Knappskog1, H G Eiken, A Martinez, T Flatmark, J Apold.   

Abstract

The mutation S349P in exon 10 of the phenylalanine hydroxylase (PAH) gene was identified in one Norwegian and one Polish phenylketonuria (PKU) allele on a haplotype 1.7 background. This missense mutation in PAH codon 349 is a T to C transition in cDNA position 1267. This mutation has been reported both on haplotype 1 and 4, suggesting recurrent mutation. In two different expression systems, the pET and the pMAL systems of Escherichia coli, it was shown that the S349P mutation, introduced by site directed mutagenesis, results in complete loss of enzymatic activity. Thus, protein instability alone does not seem to be the direct cause of the lack of activity of this PKU mutation as previously reported.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7860062     DOI: 10.1007/bf00209396

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  12 in total

1.  Five mutations at the PAH locus account for almost 90% of PKU mutations in French-Canadians from eastern Quebec.

Authors:  S W John; R Rozen; R Laframboise; C Laberge; C R Scriver
Journal:  Hum Mutat       Date:  1992       Impact factor: 4.878

2.  Molecular basis of phenotypic heterogeneity in phenylketonuria.

Authors:  Y Okano; R C Eisensmith; F Güttler; U Lichter-Konecki; D S Konecki; F K Trefz; M Dasovich; T Wang; K Henriksen; H Lou
Journal:  N Engl J Med       Date:  1991-05-02       Impact factor: 91.245

3.  A prevalent missense mutation in Northern Europe associated with hyperphenylalaninaemia.

Authors:  Y Okano; R C Eisensmith; M Dasovich; T Wang; F Güttler; S L Woo
Journal:  Eur J Pediatr       Date:  1991-03       Impact factor: 3.183

4.  Molecular analysis of phenylketonuria in Denmark: 99% of the mutations detected by denaturing gradient gel electrophoresis.

Authors:  P Guldberg; K F Henriksen; F Güttler
Journal:  Genomics       Date:  1993-07       Impact factor: 5.736

5.  Associations between mutations and a VNTR in the human phenylalanine hydroxylase gene.

Authors:  A A Goltsov; R C Eisensmith; D S Konecki; U Lichter-Konecki; S L Woo
Journal:  Am J Hum Genet       Date:  1992-09       Impact factor: 11.025

6.  A missense mutation, S349P, completely inactivates phenylalanine hydroxylase in north African Jews with phenylketonuria.

Authors:  M Weinstein; R C Eisensmith; V Abadie; S Avigad; S Lyonnet; G Schwartz; A Munnich; S L Woo; Y Shiloh
Journal:  Hum Genet       Date:  1993-02       Impact factor: 4.132

7.  Identification of three novel PKU mutations among Chinese: evidence for recombination or recurrent mutation at the PAH locus.

Authors:  T Wang; Y Okano; R C Eisensmith; W H Lo; S Z Huang; Y T Zeng; L F Yuan; S R Liu; S L Woo
Journal:  Genomics       Date:  1992-05       Impact factor: 5.736

Review 8.  Molecular basis of phenylketonuria and related hyperphenylalaninemias: mutations and polymorphisms in the human phenylalanine hydroxylase gene.

Authors:  R C Eisensmith; S L Woo
Journal:  Hum Mutat       Date:  1992       Impact factor: 4.878

9.  A termination mutant prevalent in Norwegian haplotype 7 phenylketonuria genes.

Authors:  J Apold; H G Eiken; E Odland; A Fredriksen; A Bakken; J B Lorens; H Boman
Journal:  Am J Hum Genet       Date:  1990-12       Impact factor: 11.025

10.  Expression of recombinant human phenylalanine hydroxylase as fusion protein in Escherichia coli circumvents proteolytic degradation by host cell proteases. Isolation and characterization of the wild-type enzyme.

Authors:  A Martinez; P M Knappskog; S Olafsdottir; A P Døskeland; H G Eiken; R M Svebak; M Bozzini; J Apold; T Flatmark
Journal:  Biochem J       Date:  1995-03-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.